Multimedia
Featured Video
Discover NIMH: Drug Discovery and Development
One of the most exciting recent breakthroughs from research funded by the National Institute of Mental Health (NIMH) is the development of a fast-acting medication for treatment-resistant depression based on ketamine. This treatment is bringing new hope to people and families affected by major depression.
Health Topics
-
Mental Illnesses and COVID-19 Risks
-
Panic Disorder: The Symptoms
-
Director’s Innovation Speaker Series: Beyond FDA Approval: Assessing the Value of New Health Technologies
-
Mental Health and Older Adults Facebook Live Q&A
Populations
-
Mental Illnesses and COVID-19 Risks
-
Mental Health and Older Adults Facebook Live Q&A
-
Get to Know Your Brain
-
Workshop: Nonaffective Psychosis in Midlife and Beyond - Day 2
Research
-
Director’s Innovation Speaker Series: Implementing Radical Healing Strategies to Promote Health Equity
-
Director’s Innovation Speaker Series: How Looking at Genetics and Networks Led to Solving a Quantum Gravity Problem
-
Director’s Innovation Speaker Series: Beyond FDA Approval: Assessing the Value of New Health Technologies
-
Director’s Innovation Speaker Series: Cancer Control in the 21st Century with an Emphasis on Risk Reduction